checkAd

     201  0 Kommentare InspireMD Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Seite 2

    Investor Contacts:

    Craig Shore
    Chief Financial Officer
    InspireMD, Inc.
    888-776-6804
    craigs@inspiremd.com

    Lesen Sie auch

    Chuck Padala, Managing Director
    LifeSci Advisors
    646-627-8390
    chuck@lifesciadvisors.com
    investor-relations@inspiremd.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 2 von 2

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    InspireMD Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - Seite 2 TEL AVIV, Israel and MIAMI, May 18, 2023 (GLOBE NEWSWIRE) - InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that, in connection with the appointment of …